Efficacy and Safety of Ultra-low Dose Methadone as Adjuvant Analgesic in Cancer Patients With Pain

Clinical trial NCT02687347 · UNKNOWN

Trial details

NCT number: NCT02687347
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Pain, Intractable

Start date: 2016-02-01
Primary completion: 2018-02-01
Enrollment: 204

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.